Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
Clinical trial NCT03529123 · COMPLETED
Trial details
- NCT number
- NCT03529123
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2019-11-25
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.